Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear DNA cytophotometry in prostate carcinoma.

U Seppelt, E Sprenger

    Cytometry
    |May 1, 1984
    PubMed
    Summary

    DNA analysis of prostate cancer before and during treatment reveals distinct patterns. Changes in DNA histograms during endocrine therapy correlate with treatment response and patient survival, offering prognostic insights.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long term follow-up of combined radiochemotherapy for locally advanced bladder carcinoma.

    Cancer·2000
    Same author

    DNA ploidy and protein synthesis in squamous cell carcinoma cell lines of the head and neck.

    Journal of cancer research and clinical oncology·1997
    Same author

    Correlation between DNA ploidy, proliferation marker Ki-67 and early tumor progression in renal cell carcinoma. A prospective study.

    European urology·1997
    Same author

    The false negative rate in cervical cytology. Comparison of monolayers to conventional smears.

    Acta cytologica·1996
    Same author

    Quantitative DNA analysis in renal cell carcinoma. Comparison of flow and image cytometry.

    Analytical and quantitative cytology and histology·1995
    Same author

    DNA content and the proliferation marker Ki-67 as prognostic indicators in renal cell carcinoma.

    Urologia internationalis·1994

    Area of Science:

    • Uro-oncology
    • Molecular pathology
    • Medical technology

    Background:

    • Prostate carcinoma presents diagnostic challenges in grading and predicting treatment response.
    • DNA content analysis offers a potential method for objective tumor characterization.
    • Endocrine therapy is a cornerstone in managing advanced prostate cancer.

    Purpose of the Study:

    • To investigate the utility of DNA-single-cell fluorescence photometry in assessing prostate carcinoma.
    • To correlate DNA histogram patterns with tumor grade and response to endocrine therapy.
    • To evaluate the prognostic value of pre- and post-treatment DNA analysis for patient survival.

    Main Methods:

    • Eighty prostate carcinoma patients underwent fine-needle aspiration biopsy for cytologic grading.
    • DNA-single-cell fluorescence photometry was performed before and at 6-month intervals post-endocrine treatment.
    • DNA histograms were analyzed for distribution patterns (diploid, hypodiploid, bimodal, scattered) and compared to controls with benign prostatic hypertrophy.

    Main Results:

    • Pre-therapy DNA histograms showed distinct patterns correlating with tumor grades and differed significantly from benign prostatic hypertrophy.
    • Post-therapy, regressive changes included increased diploid/hypodiploid DNA values and loss of secondary peaks.
    • Progressive changes like increased scattering and new peaks correlated with clinical remission/stable disease but poorly with progression.
    • Survival correlated with pre-therapeutic DNA histograms and specific DNA parameters (median, third-quartile, maximum).

    Conclusions:

    • DNA-single-cell fluorescence photometry provides valuable insights into prostate carcinoma biology and grade.
    • Dynamic changes in DNA histograms during endocrine therapy reflect treatment response.
    • Pre-treatment DNA histogram features are significant predictors of patient survival in prostate cancer.

    Related Experiment Videos